Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 01, 2025

Get In Touch

Natco Pharma unveils Everolimus tablets 1mg in US Pharma News

Natco Pharma unveils Everolimus tablets 1mg in US

  • 31 October 2025
  • 1 day ago

Tourmaline becomes indirect wholly owned subsidiary of Novartis Pharma News

Tourmaline becomes indirect wholly owned subsidiary of Novartis

  • 30 October 2025
  • 2 days ago

Novartis to acquire Avidity Biosciences for USD 12 billion Pharma News

Novartis to acquire Avidity Biosciences for USD 12 billion

  • 27 October 2025
  • 5 days ago

Novartis Scemblix receives positive CHMP opinion for newly diagnosed CML in adults Pharma News

Novartis Scemblix receives positive CHMP opinion for newly diagnosed CML in adults

  • 19 October 2025
  • 1 week ago

Novartis commences tender offer to buy Tourmaline Bio Pharma News

Novartis commences tender offer to buy Tourmaline Bio

  • 30 September 2025
  • 1 month ago

Setback to Novartis: Delhi HC Rejects Cross-Examination Request in Post-Grant Patent Dispute Pharma News

Setback to Novartis: Delhi HC Rejects Cross-Examination Request in Post-Grant Patent Dispute

  • 26 September 2025
  • 1 month ago

Novartis Loses India Patent on Heart Failure Drug Vymada Pharma News

Novartis Loses India Patent on Heart Failure Drug Vymada

  • 19 September 2025
  • 1 month ago

Novartis, Monte Rosa Therapeutics join hands for Degraders to treat Immune-mediated diseases Pharma News

Novartis, Monte Rosa Therapeutics join hands for Degraders to treat Immune-mediated diseases

  • 16 September 2025
  • 1 month ago

Novartis to buy Tourmaline Bio for USD 1.4 billion Pharma News

Novartis to buy Tourmaline Bio for USD 1.4 billion

  • 09 September 2025
  • 1 month ago

Novartis Bags USFDA Accelerated Approval For Fabhalta For Reduction Of Proteinuria In Primary IgA Nephropathy Nephrology

Novartis Bags USFDA Accelerated Approval For Fabhalta For Reduction Of Proteinuria In Primary IgA Nephropathy

  • 28 July 2025
  • 3 months ago

Recent News

Global review links common viral infections to hig...

  • 01 November, 2025

Lower ketone levels and improved exercise capacity...

  • 01 November, 2025

Citrus Flavonoids effective nutritional adjunct to...

  • 01 November, 2025

Daily kimchi intake linked to reduced BMI and bell...

  • 01 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.